ARQT
NASDAQ · Biotechnology
Arcutis Biotherapeutics Inc
$25.29
-1.14 (-4.31%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
-5.92%
1Y
+71.23%
YTD
-12.79%
Open$26.65
Previous Close$26.43
Day High$26.88
Day Low$25.27
52W High$31.77
52W Low$13.70
Volume—
Avg Volume1.61M
Market Cap3.21B
P/E Ratio—
EPS$-0.02
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$27.64
Below
SMA 200
$20.38
Above
RSI (14)
67.5
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
14 analysts
Price Target
+239.2% upside
Current
$25.29
$25.29
Target
$85.78
$85.78
$74.20
$85.78 avg
$112.10
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 375.63M | 947.52M | 972.47M |
| Net Income | -16,126,905 | 179.95M | 161.28M |
| Profit Margin | -4.3% | 19.0% | 16.6% |
| EBITDA | -12,212,731 | 271.10M | 315.26M |
| Free Cash Flow | — | 104.36M | 84.89M |
| Rev Growth | +367.1% | -4.3% | +9.4% |
| Debt/Equity | 0.58 | 0.78 | 0.80 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $246.04 | +0.89% | 118.6 | 430.95B |
| AMGN | Amgen Inc | $410.95 | +1.51% | 25.1 | 219.39B |
| GILD | Gilead Sciences Inc | $133.21 | +1.80% | — | 165.85B |
| VRTX | Vertex Pharmaceuticals Inc | $496.07 | +2.49% | 28.3 | 124.51B |
| REGN | Regeneron Pharmaceuticals | $784.36 | +1.59% | 18.4 | 79.53B |
| ALNY | Alnylam Pharmaceuticals Inc | $219.20 | +1.43% | 35.2 | 28.41B |